Simulation-driven design of stabilized SARS-CoV-2 spike S2 immunogens During the European Federation for Medicinal

A Second-Generation Oral SARS-CoV‑2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19

Deriving general structure–activity/selectivity relationship patterns for different subfamilies of cyclin-dependent kinase inhibitors using machine

Modelling P-gp efflux may help us design better molecules   In order to treat

The Importance of Tracking "Missing' Metabolites: How and Why? Throughout the course of in-vivo

Machine Learning Strategies for Reaction Development: Toward the Low-Data Limit This useful perspective article

Discovery of an Oral, Beyond-Rule-of-Five Mcl‐1 Protein−Protein Interaction Modulator with the Potential of Treating

    A Review of Computational Approaches Targeting SARS-CoV-2 Main Protease to the Discovery